Sunday, 9 October 2016

Notes from Annual Report 2016: Poly Medicure

  • Revenue was 402.86 cr vs 381.9 cr in FY15
  • Net profit was 47.30 cr vs 61.01 cr (including 19.57 cr of exceptional items) in FY15
  • EPS was 10.72 vs 13.83 in FY15

  • PML is starting a new R&D center with an investment of 12.5cr which is to be operational by Q3 2016
  • New green field project at IMT Faridabad which is to be operational by Q3 2017 on an investment of 60cr
  • PML to focus on new market opportunities in Oncology, Nephrology & Respiratory Care segments
  • Product expansion is in process for Infusion therapy and Blood Management
  • PML is planning to launch 8-10 new products in FY17
  • PML is now exporting products to 95 countries
  • PML is now present in 3000 key hospitals in India and plans to expand to 5000 hospitals in next 2 years
  • Expanded the sales and marketing team with 80 new team members
  • The Indian medical device market is the top 20 in the world and 4th in Asia after Japan, China & South Korea
  • The medical devide sector was valued at USD 6.3 in 2013 and is expected to grow to USD25-30 by 2025
  • PML is the leading exporter of infusion therapy, blood management, gastroenterology, surgery and wound drainage,
    anesthesia and urology products
  • Over 65% of revenues come from exports
  • PML has 144 product and process patents globally; filed for additional 394 patents in India and worlwide

2 comments:

  1. This comment has been removed by a blog administrator.

    ReplyDelete
  2. what do you feel about sluggish topline?

    ReplyDelete

Stock Update: Supreme Industries

BEAR CASE RERA to impact housing demand adversely. Negative impact on pipes segment. Competition is strengthening in pipes ...